ClinicalTrials.Veeva

Menu

MRI Neurofeedback and Brain Circuits Related to Motivation in Healthy Participants

Duke University logo

Duke University

Status

Enrolling

Conditions

Motivation
Self-regulation
Memory

Treatments

Behavioral: Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05929898
1R01MH131667-01 (U.S. NIH Grant/Contract)
Pro00112672

Details and patient eligibility

About

The purpose of this research study is to understand how healthy individuals self-regulate motivation by observing brain activity using magnetic resonance imaging (MRI).

Full description

Neuromodulatory nuclei detect and transform brain network activity into simpler signals, then send neurotransmitters back out to large-scale brain networks to change their function. Such nuclei are centrally implicated in mental disorders and adaptive resilience, and their regulation remains an untapped resource for interventions. The purpose of this study is to understand how neuromodulatory nuclei detect and in turn influence distributed patterns of brain activity to impact behavior. In order to understand their regulation and effects on brain function, the investigative team has developed novel neuroimaging, behavioral, and analytic methods. These methods include: training participants to endogenously self-regulate dopaminergic midbrain and then relating midbrain activation to memory-conducive states, effort exertion, and decision making.

If the aims of this project are achieved, the investigators will have methods for regulating midbrain noninvasively, an improved understanding of its impact on learning and motivated behavior, and reliable cognitive strategies for a wide array of interventions across educational and clinical applications.

Enrollment

190 estimated patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age between 18 and 45 years
  • Male or female
  • Right-handed
  • In good general health
  • Women of childbearing capacity: use of effective method of birth control

Exclusion criteria

  • Current or diagnosis within past six months of an DSM-V Axis I or Axis II disorder (self-reported)
  • CES-D score of 20 or higher (indicating significant current depression symptoms)
  • Current or past six month use of prescription medications indicated for psychiatric conditions (e.g.,depression, anxiety)
  • Current serious medical illness (self-reported)
  • Head injury resulting in loss of consciousness
  • For participants age > 59 years, a total scaled score < 8 on the Dementia Rating Scale-2.
  • A clinically-defined neurological disorder including, but not limited to:
  • Any condition likely to be associated with increased intracranial pressure
  • Space occupying brain lesion
  • History of stroke
  • Transient ischemic attack within two years
  • Cerebral aneurysm
  • Dementia
  • Mini Mental Status Exam (MMSE) score of <24
  • Parkinson's disease
  • Huntington's disease
  • Multiple sclerosis
  • Presence of cochlear implants or other implanted electronic devices or non-removable metal (e.g., non-removable piercing, IUD)
  • History of an eye injury involving metal. Participants who worked with metal may be allowed to participate on a case-by-case basis with prior written approval from BIAC.
  • Claustrophobia or unwillingness to tolerate the confinement associated with being in the MRI scanner.
  • Weight of more than 250 pounds

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

190 participants in 3 patient groups

Intentional Versus Cue-Evoked Midbrain Activation
Experimental group
Description:
Participants meeting study inclusion will be scheduled for two sessions: one baseline behavioral visit and an fMRI session to assess the ability to self-stimulate VTA activation. Session one will include a battery of cognitive assessments and a demonstration of the reward-based learning task in session two. The experimental imaging task session will be done within one week of session one. Participants will been randomly split into two group: group one will complete a reward-based learning task before the VTA activation task and group two will complete reward task after VTA activation. During the VTA activation task, participants will be instructed to achieve a heightened state of motivation using personally relevant thoughts and imagery.
Treatment:
Behavioral: Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback
Intentional Midbrain Activation Effects on Effort-Based Decision Making
Experimental group
Description:
Participants will be randomly assigned to an MRI group or a behavioral control group. All participants will complete an effort-based learning task and a series of questionnaires in session one. Session two may include an MRI based on group assignment. Participants in the MRI group will complete the VTA activation task. Following, they will complete the effort task and questionnaires a second time. The behavioral control group will complete a second session consisting of the effort task and questionnaires.
Treatment:
Behavioral: Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback
Intentional Midbrain Activation Effects on Motivated Memory
Experimental group
Description:
Participants will take part in four sessions: visit 1-baseline + memory encoding, visit 2-memory retrieval, visit 3-memory encoding, visit 4-memory retrieval). Encoding and retrieval of the memoranda will occur 24 hours apart. Study visits will take place no more than 7 days apart. One group of participants will complete all sessions at the Center for Cognitive Neuroscience. The remainder of participants will complete the encoding sessions in the MRI machine, .
Treatment:
Behavioral: Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback

Trial contacts and locations

1

Loading...

Central trial contact

R. Alison Adock, MD, PhD; Laura Yost

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems